High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
In 2021, aducanumab, an immunotherapy targeting amyloid-β, was approved for
Alzheimer's disease (AD) by the US Food and Drug Administration thanks to positive results …
Alzheimer's disease (AD) by the US Food and Drug Administration thanks to positive results …
A low-dimensional cognitive-network space in Alzheimer's disease and frontotemporal dementia
L Pini, SC de Lange, FB Pizzini… - Alzheimer's research & …, 2022 - Springer
Background Alzheimer's disease (AD) and frontotemporal dementia (FTD) show network
dysfunctions linked with cognitive deficits. Within this framework, network abnormalities …
dysfunctions linked with cognitive deficits. Within this framework, network abnormalities …
Prediction of misfolded proteins spreading in Alzheimer's disease using machine learning and spreading models
The pervasive impact of Alzheimer's disease on aging society represents one of the main
challenges at this time. Current investigations highlight 2 specific misfolded proteins in its …
challenges at this time. Current investigations highlight 2 specific misfolded proteins in its …
Care setting Transitions for people with dementia: qualitative perspectives of current and former Care Partners
KG Radcliffe, M Halim, CS Ritchie… - American Journal of …, 2023 - journals.sagepub.com
Care partners (CP) of people with dementia (PWD) report that decisions about care setting
are aided by the support of healthcare providers. However, providers are often …
are aided by the support of healthcare providers. However, providers are often …
The Missing Piece of the Puzzle: High-Quality, Nonhospice, Community-Based Care for Persons with Dementia.
MD Aldridge - Journal of Palliative Medicine, 2022 - search.ebscohost.com
The article addresses the locus of care for persons with dementia (PWD) who are living in
the community and are not at the end of life, and those who do not choose to enroll with …
the community and are not at the end of life, and those who do not choose to enroll with …
Prediction of misfolded proteins spreading in Alzheimer's disease using machine learning
The pervasive impact of Alzheimer's disease on aging society represents one of the main
challenges at this time. Current investigations highlight two specific misfolded proteins in its …
challenges at this time. Current investigations highlight two specific misfolded proteins in its …
[引用][C] Monoclonal anti‐amyloid antibodies for the treatment of Alzheimer's disease and the hesitant geriatrician
NA Chin, E Widera, SA Brangman… - Journal of the …, 2024 - Wiley Online Library
The US Food and Drug Administration (FDA) approval of monoclonal antibodies (MAB)
targeting amyloid protein for treatment of Alzheimer's disease has ushered in a new era in …
targeting amyloid protein for treatment of Alzheimer's disease has ushered in a new era in …
[引用][C] Of education and public policy: Aducanumab
NE Lundebjerg, PA Hollmann… - Journal of the American …, 2022 - Wiley Online Library
See related letter by Padovani et al.